Australia’s Therapeutic Goods Administration (TGA) has approved the Pfizer-BioNTech Covid-19 vaccine for use in people aged 16 years and above. Two doses of the vaccine are to be administered at the scheduled time.
The Australian Prime Minister, Scott Morrison stated that the country’s medical regulator was one of the first in the world to complete a comprehensive approval of the Pfizer-BioNTech vaccine.
According to the Health Minister, Greg Hunt, priority groups will receive the vaccine, starting in late February with plans to deliver 80,000 doses per week.
The country has also warned that AstraZeneca’s international production issues could delay the distribution of a locally manufactured shots.
Meanwhile, Pfizer and BioNTech have entered into an advance purchase agreement with COVAX to supply up to 40 million doses of their Covid-19 vaccine throughout this year.
Pfizer chairman and CEO Albert Bourla said: “We share the mission of COVAX and are proud to work together so that developing countries have the same access as the rest of the world, which will bring us another step closer to ending this global pandemic and proving that Science Will Win for everyone, everywhere.”
Pfizer noted that the initial doses are planned to be supplied in the first quarter of this year at a not-for-profit price.